Foundation For Neglected Disease Research Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 18-12-2024
- Paid Up Capital ₹ 0.10 M
as on 18-12-2024
- Company Age 10 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 46.00%
(FY 2023)
- Profit 111.00%
(FY 2023)
- Ebitda 1.17%
(FY 2023)
- Net Worth 43.71%
(FY 2023)
- Total Assets 5.98%
(FY 2023)
About Foundation For Neglected Disease Research
The Company is engaged in the Research & Development Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Foundation For Neglected Disease Research India is Shridhar Narayanan as CEO. Suri Venkatachalam, Shridhar Narayanan, Radha Shandil, and One other member serve as directors at the Company.
- CIN/LLPIN
U73200KA2014NPL076126
- Company No.
076126
- Company Classification
Private Not For Profit Company
- Incorporation Date
01 Sep 2014
- Date of AGM
11 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangalore Rural, Karnataka, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Foundation For Neglected Disease Research?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shridhar Narayanan  | CEO | 10-Jun-2017 | Current |
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Shridhar Narayanan | Whole-Time Director and Ceo | 01-Sep-2014 | Current |
| Radha Shandil | Whole-Time Director | 05-Sep-2014 | Current |
| Suri Venkatachalam | Director | 10-Jun-2017 | Current |
| Hemalatha Krishnamurthy | Director | 09-Jul-2020 | Current |
Financial Performance and Corporate Structure Insights of Foundation For Neglected Disease Research.
Foundation For Neglected Disease Research, for the financial year ended 2023, experienced significant growth in revenue, with a 46% increase. The company also saw a substantial improvement in profitability, with a 111% increase in profit. The company's net worth Soared by an impressive increase of 43.71%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Foundation For Neglected Disease Research?
In 2023, Foundation For Neglected Disease Research had a promoter holding of 58.00% and a public holding of 42.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Foundation For Neglected Disease Research?
Foundation For Neglected Disease Research has a workforce of 29 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Foundation For Neglected Disease Research, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Foundation For Neglected Disease Research's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
